Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide ... twice daily from a Diskusâ„¢ inhaler for a 4-week run-in period ...
Last year saw a key development in the US respiratory diseases market when Mylan finally launched its generic version of GlaxoSmithKline’s blockbuster inhaler Advair (fluticasone+salmeterol).
Seretide (salmeterol xinafoate/fluticasone propionate ... under the Sirdupla brand name and in a pressurised metered dose inhaler (pMDI) device developed by 3M. Like its branded rival ...
News Medical on MSN4d
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPDA study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...
For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...
Interventions: Salmeterol, 42 µg bid via metered-dose inhaler (MDI), and placebo bid via MDI. Measurements and results: Following an interim analysis in 26,355 subjects, the study was terminated ...
In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...
BACKGROUND Previous studies have suggested a 2:1 efficacy advantage of fluticasone propionate (FP) over beclomethasone dipropionate (BDP) in adults on high dose inhaled steroids and children on low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback